Cargando…

Cancer-selective, single agent chemoradiosensitising gold nanoparticles

Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous ski...

Descripción completa

Detalles Bibliográficos
Autores principales: Grellet, Sophie, Tzelepi, Konstantina, Roskamp, Meike, Williams, Phil, Sharif, Aquila, Slade-Carter, Richard, Goldie, Peter, Whilde, Nicky, Śmiałek, Małgorzata A., Mason, Nigel J., Golding, Jon P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507319/
https://www.ncbi.nlm.nih.gov/pubmed/28700660
http://dx.doi.org/10.1371/journal.pone.0181103
_version_ 1783249717440806912
author Grellet, Sophie
Tzelepi, Konstantina
Roskamp, Meike
Williams, Phil
Sharif, Aquila
Slade-Carter, Richard
Goldie, Peter
Whilde, Nicky
Śmiałek, Małgorzata A.
Mason, Nigel J.
Golding, Jon P.
author_facet Grellet, Sophie
Tzelepi, Konstantina
Roskamp, Meike
Williams, Phil
Sharif, Aquila
Slade-Carter, Richard
Goldie, Peter
Whilde, Nicky
Śmiałek, Małgorzata A.
Mason, Nigel J.
Golding, Jon P.
author_sort Grellet, Sophie
collection PubMed
description Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50:50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics.
format Online
Article
Text
id pubmed-5507319
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55073192017-07-25 Cancer-selective, single agent chemoradiosensitising gold nanoparticles Grellet, Sophie Tzelepi, Konstantina Roskamp, Meike Williams, Phil Sharif, Aquila Slade-Carter, Richard Goldie, Peter Whilde, Nicky Śmiałek, Małgorzata A. Mason, Nigel J. Golding, Jon P. PLoS One Research Article Two nanometre gold nanoparticles (AuNPs), bearing sugar moieties and/or thiol-polyethylene glycol-amine (PEG-amine), were synthesised and evaluated for their in vitro toxicity and ability to radiosensitise cells with 220 kV and 6 MV X-rays, using four cell lines representing normal and cancerous skin and breast tissues. Acute 3 h exposure of cells to AuNPs, bearing PEG-amine only or a 50:50 ratio of alpha-galactose derivative and PEG-amine resulted in selective uptake and toxicity towards cancer cells at unprecedentedly low nanomolar concentrations. Chemotoxicity was prevented by co-administration of N-acetyl cysteine antioxidant, or partially prevented by the caspase inhibitor Z-VAD-FMK. In addition to their intrinsic cancer-selective chemotoxicity, these AuNPs acted as radiosensitisers in combination with 220 kV or 6 MV X-rays. The ability of AuNPs bearing simple ligands to act as cancer-selective chemoradiosensitisers at low concentrations is a novel discovery that holds great promise in developing low-cost cancer nanotherapeutics. Public Library of Science 2017-07-10 /pmc/articles/PMC5507319/ /pubmed/28700660 http://dx.doi.org/10.1371/journal.pone.0181103 Text en © 2017 Grellet et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Grellet, Sophie
Tzelepi, Konstantina
Roskamp, Meike
Williams, Phil
Sharif, Aquila
Slade-Carter, Richard
Goldie, Peter
Whilde, Nicky
Śmiałek, Małgorzata A.
Mason, Nigel J.
Golding, Jon P.
Cancer-selective, single agent chemoradiosensitising gold nanoparticles
title Cancer-selective, single agent chemoradiosensitising gold nanoparticles
title_full Cancer-selective, single agent chemoradiosensitising gold nanoparticles
title_fullStr Cancer-selective, single agent chemoradiosensitising gold nanoparticles
title_full_unstemmed Cancer-selective, single agent chemoradiosensitising gold nanoparticles
title_short Cancer-selective, single agent chemoradiosensitising gold nanoparticles
title_sort cancer-selective, single agent chemoradiosensitising gold nanoparticles
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507319/
https://www.ncbi.nlm.nih.gov/pubmed/28700660
http://dx.doi.org/10.1371/journal.pone.0181103
work_keys_str_mv AT grelletsophie cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT tzelepikonstantina cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT roskampmeike cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT williamsphil cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT sharifaquila cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT sladecarterrichard cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT goldiepeter cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT whildenicky cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT smiałekmałgorzataa cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT masonnigelj cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles
AT goldingjonp cancerselectivesingleagentchemoradiosensitisinggoldnanoparticles